Jeffrey F. Eisenberg
2021
In 2021, Jeffrey F. Eisenberg earned a total compensation of $750.2K as Chief Executive Officer at Xenetic Biosciences, a 68% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,438 |
|---|---|
| Option Awards | $234,052 |
| Salary | $367,500 |
| Other | $29,241 |
| Total | $750,231 |
Eisenberg received $367.5K in salary, accounting for 49% of the total pay in 2021.
Eisenberg also received $119.4K in non-equity incentive plan, $234.1K in option awards and $29.2K in other compensation.
Rankings
In 2021, Jeffrey F. Eisenberg's compensation ranked 9,677th out of 12,405 executives tracked by ExecPay. In other words, Eisenberg earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,677 out of 12,405 | 22nd |
Division Manufacturing | 4,280 out of 5,494 | 22nd |
Major group Chemicals And Allied Products | 1,895 out of 2,369 | 20th |
Industry group Drugs | 1,681 out of 2,090 | 20th |
Industry Pharmaceutical Preparations | 1,249 out of 1,537 | 19th |
Source: SEC filing on October 17, 2022.
Eisenberg's colleagues
We found two more compensation records of executives who worked with Jeffrey F. Eisenberg at Xenetic Biosciences in 2021.